GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins December 04, 2024
Displaying entries 451 - 500 of 39437 in total
PDB ID UniProt ID ▼ Title Descriptor
7EW6 S4Z1D9 Barley photosystem I-LHCI-Lhca5 supercomplex
7F9O S4Z1D9 PSI-NDH supercomplex of Barley
7EWK S4Z1D9 Barley photosystem I-LHCI-Lhca6 supercomplex
7EW6 S4YZ47 Barley photosystem I-LHCI-Lhca5 supercomplex
7F9O S4YZ47 PSI-NDH supercomplex of Barley
6D7C S4V1Z7 The crystal structure of hemagglutinin from A/Hong Kong/61/2016 H7N9 influenza virus
1KTB S43413 The Structure of alpha-N-Acetylgalactosaminidase alpha-N-acetylgalactosaminidase (E.C.3.2.1.49)
1KTC S43413 The Structure of alpha-N-Acetylgalactosaminidase
5KN7 S3TFW2 Lipid A secondary acyltransferase LpxM from Acinetobacter baumannii
5KNK S3TFW2 Lipid A secondary acyltransferase LpxM from Acinetobacter baumannii with catalytic residue substitution (E127A)
1IGF S38864 CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS IGG1 FAB' FRAGMENT (B13I2)
2IGF S38864 CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS IGG1 FAB' FRAGMENT (B13I2) COMPLEX WITH PEPTIDE (RESIDUES 69-87 OF MYOHEMERYTHRIN)
1JLX S24263 AGGLUTININ IN COMPLEX WITH T-DISACCHARIDE
8AKN S1E9P3 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the terminating ribosome
8AM9 S1E9P3 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the elongating ribosome
8ANA S1E9P3 Cryo-EM structure of the proline-rich antimicrobial peptide drosocin bound to the 50S ribosomal subunit
1J8H S18894 Crystal Structure of a Complex of a Human alpha/beta-T cell Receptor, Influenza HA Antigen Peptide, and MHC Class II Molecule, HLA-DR4
1CR7 S14765 PEANUT LECTIN-LACTOSE COMPLEX MONOCLINIC FORM
1MCO S14675 THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION IMMUNOGLOBULIN G1 (IGG1) (MCG) WITH A HINGE DELETION
3WCT S0BCU7 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Oxygenated form
3WCU S0BCU7 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Deoxygenated form
3WCV S0BCU7 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: CA bound form
3WCW S0BCU7 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: MG bound form
7VLC S0BCU7 Oxy-deoxy intermediate of V2 hemoglobin at 78% oxygen saturation
7VLD S0BCU7 Oxy-deoxy intermediate of V2 hemoglobin at 69% oxygen saturation
7VLE S0BCU7 Oxy-deoxy intermediate of V2 hemoglobin at 55% oxygen saturation
7VLF S0BCU7 Oxy-deoxy intermediate of V2 hemoglobin at 26% oxygen saturation
3WCT S0BBU7 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Oxygenated form
3WCU S0BBU7 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Deoxygenated form
3WCV S0BBU7 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: CA bound form
3WCW S0BBU7 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: MG bound form
7VLC S0BBU7 Oxy-deoxy intermediate of V2 hemoglobin at 78% oxygen saturation
7VLD S0BBU7 Oxy-deoxy intermediate of V2 hemoglobin at 69% oxygen saturation
7VLE S0BBU7 Oxy-deoxy intermediate of V2 hemoglobin at 55% oxygen saturation
7VLF S0BBU7 Oxy-deoxy intermediate of V2 hemoglobin at 26% oxygen saturation
3WCT S0BBR6 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Oxygenated form
3WCU S0BBR6 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Deoxygenated form
3WCV S0BBR6 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: CA bound form
3WCW S0BBR6 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: MG bound form
7VLC S0BBR6 Oxy-deoxy intermediate of V2 hemoglobin at 78% oxygen saturation
7VLD S0BBR6 Oxy-deoxy intermediate of V2 hemoglobin at 69% oxygen saturation
7VLE S0BBR6 Oxy-deoxy intermediate of V2 hemoglobin at 55% oxygen saturation
7VLF S0BBR6 Oxy-deoxy intermediate of V2 hemoglobin at 26% oxygen saturation
3WCT S0BAP9 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Oxygenated form
3WCU S0BAP9 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Deoxygenated form
3WCV S0BAP9 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: CA bound form
3WCW S0BAP9 The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: MG bound form
7VLC S0BAP9 Oxy-deoxy intermediate of V2 hemoglobin at 78% oxygen saturation
7VLD S0BAP9 Oxy-deoxy intermediate of V2 hemoglobin at 69% oxygen saturation
7VLE S0BAP9 Oxy-deoxy intermediate of V2 hemoglobin at 55% oxygen saturation

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024